STN-1013400

N/A

Report date: 2022/12/03 23:08:12
NME

Base Information

Drug NameSTN-1013400
Drug Alias NameSTN1013400STN-1013400AFDX0250BS
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMuscarinic acetylcholine receptor M2 antagonists
TargetsMuscarinic acetylcholine receptor M2
Therapy Area/IndicationsMyopia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesSanten Pharmaceutical Co LtdSanten Pharmaceutical China Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSanten Pharmaceutical Co LtdSanten Pharmaceutical China Co LtdSanten Pharmaceutical Co Ltd Noto Plant
Inactive CompaniesN/A
Active IndicationsMyopia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A